INDICATION AND LIMITATION OF USE

Vyvanse is indicated for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in patients ages 6 and above. Vyvanse is not indicated or recommended for weight loss. Use of other sympathomimetic drugs for weight loss has been associated with serious cardiovascular adverse events. The safety and effectiveness of Vyvanse for the treatment of obesity have not been established.

This site is intended for US healthcare professionals only.

IMPORTANT SAFETY INFORMATION

WARNING: ABUSE AND DEPENDENCE

  • CNS stimulants (amphetamines and methylphenidate-containing products), including Vyvanse, have a high potential for abuse and dependence. Assess the risk of abuse prior to prescribing and monitor for signs of abuse and dependence while on therapy.
Full Safety Information Below

Vyvanse is indicated for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in patients ages 6 and above. Vyvanse is not indicated or recommended for weight loss. Use of other sympathomimetic drugs for weight loss has been associated with serious cardiovascular adverse events. The safety and effectiveness of Vyvanse for the treatment of obesity have not been established.

IMPORTANT SAFETY INFORMATION    This site is intended for US healthcare professionals only.

WARNING: ABUSE AND DEPENDENCE

  • | CNS stimulants (amphetamines and methylphenidate-containing products), including Vyvanse, have a high potential for abuse and dependence. Assess the risk of abuse prior to prescribing and monitor for signs of abuse and dependence while on therapy.
Full Safety Information Below

Vyvanse Pro Resource Center

The Pro Resource Center focuses on providing information and resources that complement the work you do with your ADHD adult patients. Whether your patients need help understanding co-pay costs or tracking symptoms, our Pro Resource Center can help provide you with patient-friendly resources. Use the tools below to learn more.

  • Look up Vyvanse Coverage and Co-pay Information

    Vyvanse has Tier 2 / Preferred formulary status for 82% of commercial plans in the US*

    Check patient’s individual health plan coverage and costs as plan status may change without notice.

    *Data Provided by Fingertip Formulary and is current as of [Date]. Total number of Commercial lives showing Tier 1, Tier 2, or Tier 3 Preferred tier status (excluding any plans showing a reason code of 93 or 94 - State Medicaid non-preferred) divided by the total number of Commercial lives nationally (excluding any plans showing total lives as Not Available). Check patient’s individual health plan as plan status and coverage may change without notice.

    Formulary results for

    Health plan provider:

    Status:

    Co-pay:

    Available health plan information:


    Health plan:

    Results data are provided by Fingertip Formulary® as of .

    Tier (Tier#) = A formulary category that determines the amount of co-pay required for a drug. The number of tiers varies by plan and can range from 1 to 7.

    Prior authorization (PA) = Approval process in which a prescriber must justify the use of a prescribed medication.

    Step edit (SE) = Prescription for a medication is filled only after treatment failure on one or more alternatives.

    Not covered (NC) = Drugs that are not covered by the plan.

    Not available (NA) = Data are not available.

  • Enroll Eligible Patients for a Savings Offer*

    Only licensed healthcare professionals may register. Complete the form to download a printable savings offer for your eligible patient. If you are not a healthcare professional, visit vyvansesavings.com.

    • *Restrictions apply. See savings offer for details.

    Required fields. Step 1 of 2 Step 2 of 2

      If you are a patient, visit vyvansesavings.com.

      Shire US Inc. will not sell or provide your e-mail information to other parties without your permission. This information will not be used for any purpose other than what is explained in our Privacy Policy Statement, available by clicking on this link: Review Shire Privacy Policy Statement. This consent will be in effect until such time as you opt out of the program.

      Thank You!

      Need to download another savings offer? Start Here.

    • Get the latest from Vyvanse

    HAVE A QUESTION? Request a representative to get answers

    Thank you for your request.

    A Vyvanse representative will be contacting you shortly.

      How would you like to be contacted?

      Educational resources for you and your adult patients

      These educational resources are available to help you facilitate a more meaningful and informed discussion about ADHD and reimbursement with your patients.

      EDUCATIONAL DOWNLOADS

      WORKING WITH YOUR PATIENTS

      • Symptom Checklist For Adults

        Use this symptom checklist for discussing ADHD with your adult patients

        Download
      • Proper Medication Use Guide

        Help your patients understand the proper use of stimulant medications for ADHD

        Download

      You are about to leave vyvansepro.com.

      Please be advised that Shire has no control over the content or presentation of the site you are about to view.

      Cancel Continue
      CLOSE
      Scroll for additional Important Safety Info & see Full Prescribing Information.